Yourgene Health PLC AGM update and investor presentation (3957Y)
September 09 2020 - 2:00AM
UK Regulatory
TIDMYGEN
RNS Number : 3957Y
Yourgene Health PLC
09 September 2020
Yourgene Health plc
("Yourgene" or the "Group" or the "Company")
AGM update and investor presentation
Manchester, UK - 9 September 2020: Yourgene (AIM: YGEN), the
international molecular diagnostics group, announces that further
to the Notice of AGM issued on 28 August 2020, the Company
announces details of how to join the AGM, which is to be held
virtually via Investor Meet Company platform on 22 September 2020
at 4.00pm. All existing and potential shareholders are invited and
encouraged to join.
The Company's CEO, Lyn Rees, will provide shareholders with a
short presentation after the formal business of the AGM concludes
and there will be an opportunity for investors to ask questions. As
previously announced, all voting must be done via proxy ahead of
the meeting - for further details see the RNS issued by Yourgene on
28 August 2020 https://bit.ly/357KsDo .
The Company is committed to ensuring that there are appropriate
communication structures for all elements of its shareholder base
so that its strategy, business model and performance are clearly
understood.
Questions can be submitted pre-event via your IMC dashboard or
at any time during the live presentation via the "Ask a Question"
function. Although the Company may not be in a position to answer
every question it receives, it will address the most prominent
within the confines of information already disclosed to the market.
Responses to the Q&A from the live presentation will be
published at the earliest opportunity on the Investor Meet Company
platform.
Investors can sign up to Investor Meet Company for free and add
to meet Yourgene Health via:
https://www.investormeetcompany.com/yourgene-health-plc/register-investor
Investors who have already registered for the Investor Meet
Company platform and added to meet the Company will be
automatically invited.
Investors who have already registered via Walbrook PR, are
encouraged to sign up to the IMC platform.
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880
Liam Murray / James Caithie / Ludovico
Lazzaretti
N+1 Singer (Joint Corporate Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / Tom Salvesen / George
Tzimas
Stifel Nicolaus Europe Limited (Joint Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / Mob: 07584
391 303
About Yourgene Health plc
Yourgene is an international molecular diagnostics group which
develops and commercialises genetic products and services. The
group works in partnership with global leaders in DNA technology to
advance diagnostic science.
Yourgene develops and commercialises simple and accurate
molecular diagnostic solutions, for reproductive health and
molecular genetics. The Group's products include non-invasive
prenatal tests (NIPT) for Down's Syndrome and other genetic
disorders, Cystic Fibrosis screening tests, invasive rapid
aneuploidy tests, male infertility tests and genetic disease tests.
Yourgene's commercial footprint is already established in the UK,
Europe, the Middle East, Africa and Asia.
Our product development, research service and commercial
capabilities extend across the lifecycle of genetic test
development including regulatory submissions. Through our technical
expertise and partnerships, Yourgene is also extending its genetic
testing offering into oncology.
Yourgene is headquartered in Manchester, UK with offices in
Taipei and Singapore, and is listed on the London Stock Exchange's
AIM market under the ticker "YGEN". For more information, visit
www.yourgene-health.com and follow us on twitter
@Yourgene_Health.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCDVLFBBKLLBBF
(END) Dow Jones Newswires
September 09, 2020 02:00 ET (06:00 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2024 to May 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From May 2023 to May 2024